Cheng, Cheng-I <br/><br/>
Valsartan impairs angiogenesis of mesenchymal stem cells through Akt pathway.  [electronic resource] 

 -  International journal of cardiology  Sep 2013 
 - 2765-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1874-1754 
<br/><br/><label>Standard No.: </label>10.1016/j.ijcard.2012.06.128  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Angiotensin II Type 1 Receptor Blockers--pharmacology<br/>Animals<br/>Human Umbilical Vein Endothelial Cells--drug effects<br/>Humans<br/>Male<br/>Mesenchymal Stem Cells--drug effects<br/>Mice<br/>Mice, Inbred ICR<br/>Mice, Transgenic<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Tetrazoles--pharmacology<br/>Valine--analogs & derivatives<br/>Valsartan